CVI Holdings’s AEON Biopharma AEON Stock Holding History

CVI Holdings’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,979	Closed	-$5.05M	–	416
2022 Q4	$5.05M	Sell	6,979 -176	-2%	-$126K	0.64%	37
2022 Q3	$5.08M	Hold	7,155	–	–	0.39%	64
2022 Q2	$5.05M	Hold	7,155	–	–	0.37%	65
2022 Q1	$5.04M	Buy	7,155 +211	+3%	+$148K	0.33%	72
2021 Q4	$4.86M	Hold	6,944	–	–	0.32%	91
2021 Q3	$4.87M	Hold	6,944	–	–	0.3%	100
2021 Q2	$4.82M	Buy	+6,944	New	+$4.85M	0.33%	99

Other funds holding AEON

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

GCWM

Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

CVI Holdings's AEON Position: Q1 2023 in Review

CVI Holdings sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 6,979 shares — an estimated $5.05M sold.

CVI Holdings first reported a position in AEON in Q2 2021 and held it in 7 quarters. The position peaked at $5.08M in Q3 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

CVI Holdings reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
CVI Holdings sold 6,979 AEON Biopharma shares in Q1 2023, an estimated $5.05M.
CVI Holdings first reported a position in AEON Biopharma in Q2 2021 and held it in 7 quarters.
CVI Holdings's AEON Biopharma position peaked at $5.08M in Q3 2022.
21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.